title: SV119-gold nanocage conjugates: a new platform for targeting cancer cells via sigma-2 receptors.
abstract: We have functionalized the surface of gold nanocages with SV119, a synthetic small molecule specific to sigma-2 receptors, and then demonstrated the capability of this new class of conjugates for targeting cancer cells.
authors: Department of Biomedical Engineering, Washington University, St Louis, MO 63130, USA.
authors: Yucai
authors: Y
authors: Wang
authors: Jinbin
authors: J
authors: Xu
authors: Xiaohu
authors: X
authors: Xia
authors: Miaoxin
authors: M
authors: Yang
authors: Suwanna
authors: S
authors: Vangveravong
authors: Jingyi
authors: J
authors: Chen
authors: Robert H
authors: RH
authors: Mach
authors: Younan
authors: Y
authors: Xia
mesh_terms: D045744:Cell Line, Tumor; D006046:Gold / Q000737:chemistry*; D006801:Humans; D008422:Materials Testing; D053769:Nanocapsules / Q000737:chemistry* / Q000648:ultrastructure; D050997:Nanomedicine / Q000379:methods*; D049329:Nanostructures / Q000737:chemistry* / Q000648:ultrastructure; D009374:Neoplasms, Experimental / Q000737:chemistry* / Q000378:metabolism* / Q000473:pathology; D010316:Particle Size; D017480:Receptors, sigma / Q000378:metabolism*
chemical_list: D053769:Nanocapsules; D017480:Receptors, sigma; C106107:sigma-2 receptor; D006046:Gold